High Insider Ownership Growth Companies To Watch In February 2025

As global markets continue to navigate the complexities of rising inflation and shifting trade policies, U.S. stock indexes have climbed toward record highs, with growth stocks leading the charge. In this environment, companies with high insider ownership can offer unique insights into potential future performance, as insiders often have a vested interest in the company's success and may align their strategies accordingly.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Seojin SystemLtd (KOSDAQ:A178320)	32.1%	39.9%
Clinuvel Pharmaceuticals (ASX:CUV)	10.4%	26.2%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Pricol (NSEI:PRICOLLTD)	25.4%	25.2%
Laopu Gold (SEHK:6181)	36.4%	39.1%
Pharma Mar (BME:PHM)	11.9%	45.4%
HANA Micron (KOSDAQ:A067310)	18.3%	119.4%
Plenti Group (ASX:PLT)	12.7%	120.1%
Fulin Precision (SZSE:300432)	13.6%	71%
Findi (ASX:FND)	35.8%	133.7%

Click here to see the full list of 1458 stocks from our Fast Growing Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Pharma Mar (BME:PHM)

Simply Wall St Growth Rating: ★★★★★★

Overview: Pharma Mar, S.A. is a biopharmaceutical company focused on the research, development, production, and commercialization of bio-active principles for oncology across various countries including Spain, Italy, Germany, Ireland, France, the rest of the EU and the United States; it has a market cap of approximately €1.71 billion.

Operations: The company generates revenue primarily from its oncology segment, which amounts to €154.75 million.

Insider Ownership: 11.9%

Revenue Growth Forecast: 23.8% p.a.

Pharma Mar shows potential as a growth company with high insider ownership. Its earnings are forecast to grow significantly at 45.4% annually, outpacing the Spanish market's 7.3%. Revenue is also expected to rise by 23.8% per year, exceeding the market average of 5.2%. Despite a volatile share price and reduced profit margins from last year, it trades at 30.3% below its estimated fair value, indicating possible undervaluation amidst strong growth prospects.

• Delve into the full analysis future growth report here for a deeper understanding of Pharma Mar.
• The valuation report we've compiled suggests that Pharma Mar's current price could be inflated.

BICO Group (OM:BICO)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BICO Group AB (publ) is a bioconvergence company with operations in North America, Europe, Asia, and internationally, and has a market cap of SEK2.93 billion.

Operations: BICO Group generates revenue from its operations across North America, Europe, Asia, and other international markets.

Insider Ownership: 25.2%

Revenue Growth Forecast: 13.2% p.a.

BICO Group demonstrates potential with high insider ownership, despite recent volatility. The company's revenue is forecast to grow at 13.2% annually, surpassing the Swedish market average of 1%. While currently unprofitable, BICO is expected to achieve profitability within three years, reflecting above-average market growth. Recent earnings showed a significant turnaround with a net income of SEK 346.8 million in Q4 2024 compared to a loss the previous year, highlighting positive momentum amidst its competitive valuation.

• Get an in-depth perspective on BICO Group's performance by reading our analyst estimates report here.
• According our valuation report, there's an indication that BICO Group's share price might be on the cheaper side.

Shenzhen SEICHI Technologies (SHSE:688627)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen SEICHI Technologies Co., Ltd. specializes in the R&D, production, and sale of new display device testing equipment in China with a market cap of CN¥7.69 billion.

Operations: Revenue Segments (in millions of CN¥):

Insider Ownership: 18.6%

Revenue Growth Forecast: 29.1% p.a.

Shenzhen SEICHI Technologies shows promise with significant insider ownership, although its share price has been volatile recently. The company’s earnings are projected to grow at a substantial 42.62% annually over the next three years, outpacing the Chinese market average of 25%. Revenue is also expected to rise by 29.1% per year, exceeding market growth rates. However, profit margins have declined from last year and return on equity remains low at a forecasted 11.5%.

• Take a closer look at Shenzhen SEICHI Technologies' potential here in our earnings growth report.
• According our valuation report, there's an indication that Shenzhen SEICHI Technologies' share price might be on the expensive side.

Where To Now?

• Unlock our comprehensive list of 1458 Fast Growing Companies With High Insider Ownership by clicking here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com